With rising numbers of COVID-19 infections and as the fight against the novel coronavirus continues, Novavax received $1.6 billion in federal funding to support the clinical development of the company’s vaccine candidate, NVX‑CoV2373. Gaithersburg, ...
WASHINGTON--(BUSINESS WIRE)-- The Milken Institute, the nonprofit, nonpartisan think tank, and First Person, a San Francisco design and storytelling company, together tell the urgent story of the global race for a COVID-19 vaccine in a newly released ...
Researchers in Pittsburgh and Boston are moving forward with research into two separate coronavirus vaccine programs against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. The work of the University of Pittsburgh School of Medicine ...
British scientists say a former nurse has become the first person in the country to receive an experimental Ebola vaccine in an early trial to test its safety. Ruth Atkins, 48, got the injection on Wednesday in Oxford, the first of 60 healthy volunt ...
Johnson & Johnson announced it will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate with its partners in global health to deliver immediate relief aid to address the current Ebola o ...
Ebola Vaccine is in Safety Testing This Aug. 12, 2014 file photo shows a healthcare worker walking near a Ebola isolation unit wearing protective gear against the virus at Kenema Government Hospital in Kenema, Sierra Leone. Federal researchers next ...
Ebola Outbreak an International Public Health Emergency Declared by WHO Director General of the World Health Organization, WHO, China's Margaret Chan and Assistant Director General for Health Security Keiji Fukuda of the US, right, share a word duri ...
Charlie Arntzen has worked tirelessly on new platforms to deliver drugs. He has focused on plant-based drug delivery systems, testing a wide range of plants as possible “manufacturing platforms” for therapeutics for the developing world. Now Arntze ...
